Navigation Links
New Technique Could Revolutionize Melanoma Diagnosis and Treatment

Melanoma, a form of skin cancer is the most common tumor to be diagnosed. It has a 99% cure rate if detected early, say researchers from University Hospital of Navarra. // Sadly, the incidence melanoma has been increasing steadily over the recent years. It is the number one killer of women aged between 19 and 50 years. In the U.S., the number of new cases has risen from 6000 to 9000 in just 10 years.

Two main factors regarded to play a major role in the incidence of melanoma are genetic predisposition and exposure to UV light. More specifically, those who suffer form blisters and burns could face an increased risk of developing melanoma following exposure.

The survival rate of melanoma is considerably high. The early detection promises effective surgical treatment of the cutaneous tumor. The diagnosis of melanoma has so far been based on skin biopsy results and clinical experience. This condition has however changed now, with development of the so-called dermatoscopic techniques.

It involves application of a suitable substance over the skin that ensures transparency of the cornel layer. Enhanced visualization of a specific area of the skin can be facilitated through use of different devices. It can be used to differentiate malignant condition from non-malignant conditions, thereby eliminating the need for surgery.

Two widely used techniques in this regard are reflectance confocal microscopy and multiespectral digital dermatoscopy. The former is based on analysis of specific areas of the skin lesion (badly defined or irregular edges). The latter involves photography of the pigmented skin lesion. The images are then processed to facilitate an accurate diagnosis. The patient can then be given the best possible treatment.

The technique is expected to be approved for commercial use in health centers by the FDA (Food and Drug Administration of the USA) in a year. If approved, it could revolutionize the diagnosis and treatm ent of skin cancer.


'"/>




Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. New Technique to Study Infants Brain.
3. New Technique For Benign Breast Tumors
4. Preventing Strokes Using Less Invasive Techniques
5. New Technique To Detect Activity Of Drugs In The Body
6. New Technique To Test Stem Cells That Heal The Heart
7. A New Technique For Prediction Of Adult Height
8. Novel Technique For Targeting Small-Cell Lung Cancer
9. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
10. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
11. New Technique Enables Better Nursing Of Robin Sequence Infants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... Orion, Michigan (PRWEB) , ... April 29, 2017 ... ... signs of fertility and infertility. These methods observe the naturally occurring signs ... in intercourse during the most fertile time. , Natural family planning and ...
(Date:4/29/2017)... Baltimore, MD (PRWEB) , ... April 29, 2017 , ... ... noisy jobs, so what are Americans doing in their leisure time that causes hearing ... assess lifestyle habits that may be contributing to hearing loss, as well as schedule ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield ... credit rating of “A” and its outlook as “stable.” At the same time, the ... have fallen in recent years, dip below “capital adequacy” thresholds required for its strong ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: